CAS NO: | 70374-39-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
1 g | 电议 |
5 g | 电议 |
生物活性 | Lornoxicam (Chlortenoxicam), aCOX-1andCOX-2 inhibitor, is a new nonsteroidal anti-inflammatory drug (NSAID). Target:COXLornoxicam showed a balanced inhibition of COX-1/-2 exhibiting the lowest IC50 (0.005 microM/0.008 microM) of the large panel of NSAIDs tested. lornoxicam showed a marked inhibition ofIL-6formation (IC50 54 microM) while the formation ofTNF-alpha, IL-1beta andIL-8was only moderately affected [1]. Lornoxicam is effective in the treatment of patients with activated osteoarthritis; the analgesic and anti-inflammatory effects of lornoxicam are significantly superior to those of rofecoxib without inferiority in tolerability [2]. Lornoxicam was fully effective for prevention of hyperalgesia [3]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 371.82 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C13H10ClN3O4S2 | ||||||||||||||||
CAS 号 | 70374-39-9 | ||||||||||||||||
中文名称 | 氯诺昔康 | ||||||||||||||||
结构分类 |
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 3.8 mg/mL(10.22 mM;Need ultrasonic and warming) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |